Active Ingredient History
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Angina Pectoris (Phase 4)
Cardiovascular Diseases (Phase 4)
Coronary Artery Disease (Phase 4)
Coronary Disease (Phase 3)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 1 (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Endocrine System Diseases (Phase 3)
Glucose Metabolism Disorders (Phase 3)
Heart Diseases (Phase 3)
Hyperglycemia (Phase 3)
Hypertension (Phase 4)
Hypoglycemia (Phase 4)
Hypoglycemic Agents (Phase 3)
Insulin Resistance (Phase 3)
Metabolic Diseases (Phase 3)
Obesity (Phase 2)
Percutaneous Coronary Intervention (Phase 4)
Proteinuria (Phase 4)
Renal Insufficiency, Chronic (Phase 3)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue